Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...

Panelists, who are over the age of 18, rate the national ads starting on the Wednesday before the Super Bowl at noon EST. The ...

While there are no studies documenting the number of physicians taking GLP-1s, a number of physicians told the Times that they've noticed many colleagues growing thinner and sharing similar eating ...

Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

GLP1RA mimic the GLP-1 hormone in the body that helps control insulin and blood glucose levels and promotes feelings of satiety. GLP-1 binds to GLP1R on cells in the brain and pancreas.

EVERYONE GET FATTER NOW!!!! refers to an exploitable meme and phrasal template featuring slightly pixellated, red, all-caps ...

Appalachia has a rich history and gorgeous landscapes, but it has also experienced rates of cancer incidence and death ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Surrogate measures of insulin resistance, based on the triglyceride-glucose index, can be used to predict the development of ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

Arrowhead Pharmaceuticals recently received the FDA NDA acceptance for Plozasiran. Read why I believe ARWR stock could be a ...

Intermittent fasting is becoming increasingly popular. But is it helpful for weight loss and other medical conditions?